Orexia Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 1

Employees

  • Latest Deal Type
  • M&A

Orexia General Information

Description

Developer of oral orexin positive modulators designed for the treatment of narcolepsy. The company's modulators develop oral therapies based on positive modulators of the G protein-coupled receptors, Orexin OX1 and OX2, enabling healthcare professionals with a product that restores orexin levels in the brain and treats the symptoms of neurological diseases.

Contact Information

Formerly Known As
Orexia Therapeutics Limited
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 24 Chiswell Street
  • London EC1Y 4YX
  • England, United Kingdom
Primary Industry
Drug Discovery
Corporate Office
  • 24 Chiswell Street
  • London EC1Y 4YX
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Orexia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 16-Feb-2021 Completed Generating Revenue
1. Early Stage VC (Series A) 06-Feb-2019 Completed Startup
To view Orexia’s complete valuation and funding history, request access »

Orexia Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Orexia’s complete cap table history, request access »

Orexia Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Orexia Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Medicxi Ventures (UK) Venture Capital Minority
To view Orexia’s complete investors history, request access »

Orexia FAQs

  • When was Orexia founded?

    Orexia was founded in 2018.

  • Where is Orexia headquartered?

    Orexia is headquartered in London, United Kingdom.

  • What is the size of Orexia?

    Orexia has 1 total employees.

  • What industry is Orexia in?

    Orexia’s primary industry is Drug Discovery.

  • Is Orexia a private or public company?

    Orexia is a Private company.

  • What is Orexia’s current revenue?

    The current revenue for Orexia is .

  • How much funding has Orexia raised over time?

    Orexia has raised $4.79M.

  • Who are Orexia’s investors?

    Medicxi Ventures (UK) has invested in Orexia.

  • When was Orexia acquired?

    Orexia was acquired on 16-Feb-2021.

  • Who acquired Orexia?

    Orexia was acquired by Centessa Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process